Improving Testing Protocol for Inhibitors in Hemophilia

Program Description: To determine whether inhibitor testing can be more efficiently, cost-effectively, and accurately executed.
Funding Partners:
  • Genentech, Inc.
Program Partners:
  • CDC's National Center on Birth Defects and Developmental Disabilities
Program Location:
  • United States of America
Birth Defects
Chronic Disease & Birth Defects
Hemophilia